scispace - formally typeset
H

Hany W. Darwish

Researcher at King Saud University

Publications -  106
Citations -  1307

Hany W. Darwish is an academic researcher from King Saud University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 20, co-authored 86 publications receiving 967 citations. Previous affiliations of Hany W. Darwish include Cairo University.

Papers
More filters
Journal ArticleDOI

Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of Amlodipine and Atorvastatin.

TL;DR: Three simple, specific, accurate and precise spectrophotometric methods manipulating ratio spectra are developed for the simultaneous determination of Amlodipine besylate and Atorvastatin calcium in tablet dosage forms and accuracy, precision, repeatability and robustness are found to be within the acceptable limit.
Journal ArticleDOI

Three different methods for determination of binary mixture of Amlodipine and Atorvastatin using dual wavelength spectrophotometry.

TL;DR: Three simple, specific, accurate and precise spectrophotometric methods depending on the proper selection of two wavelengths are developed for the simultaneous determination of Amlodipine besylate (AML) and Atorvastatin calcium (ATV) in tablet dosage forms and accuracy, precision, repeatability and robustness are found to be within the acceptable limit.
Journal ArticleDOI

Comparative study between derivative spectrophotometry and multivariate calibration as analytical tools applied for the simultaneous quantitation of Amlodipine, Valsartan and Hydrochlorothiazide

TL;DR: Four simple, accurate and specific methods were developed and validated for the simultaneous estimation of Amlodipine (AML), Valsartan (VAL) and Hydrochlorothiazide (HCT) in commercial tablets.
Journal ArticleDOI

Identification and characterization of in vitro phase I and reactive metabolites of masitinib using a LC-MS/MS method: bioactivation pathway elucidation

TL;DR: The identification and characterization of fourteen phase I metabolites of masitinib by reversed phase liquid chromatography triple quadrupole mass spectrometry (LC-QqQ-MS) showed high lability to form reactive metabolites.